Principal Jessica Cook recognized the outstanding academic achievements of Shawsheen Valley Technical High School students ...

Evangeline Lilly gained widespread recognition for her role as Kate Austen on Lost, the hit series that kept viewers hooked with its unpredictable twists and complex characters. As one of the show’s ...

Craig Conover was ready to put a ring on it before his breakup with Paige DeSorbo. In fact, the Southern Charm star revealed new details about his plans to propose to his now ex-girlfriend before ...

Craig Christian, a former boxer and notable figure in Western Australia's underworld, has died at 60 from a heart attack. Christian, previously accused in multiple violent incidents and facing ...

Free agent forward Torrey Craig has agreed to a deal with the Boston Celtics, Mark Bartelstein of Priority Sports told ESPN's Shams Charania on Thursday. Craig was waived by the Chicago Bulls ...

Click to share on Facebook (Opens in new window) Click to share on Twitter (Opens in new window) After Paige, 32, revealed on her “Giggly Squad” podcast that she and Craig, 35, parted ways ...

Entertainment gossip and news from Newsweek's network of contributors Craig Conover said he was "moving on" with his life amid the ongoing drama surrounding his breakup with Paige DeSorbo.

On the topic of manufacturing, Lilly has spent the past few years laying out billions of dollars to grow production capacity for Mounjaro and Zepbound. Despite the formal conclusion of Lilly’s ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.